1st Department of Internal Medicine, Thriasio General Hospital of Elefsina
Welcome,         Profile    Billing    Logout  
 1 Trial 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symbardi, Styliani
BEYOND, NCT05304715 / 2021-005473-10: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Completed
2
44
Europe
Bezlotoxumab, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians., Normal saline 0.9% or 5% dextrose water, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians
Hellenic Institute for the Study of Sepsis
Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome, Clostridioides Difficile Infection Recurrence, Mortality
06/23
06/23
INSPIRE, NCT05785442: Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia

Completed
2
60
Europe
Anakinra Prefilled Syringe, Kineret, Placebo, NaCl
Hellenic Institute for the Study of Sepsis
Community-acquired Pneumonia, Hospital-acquired Pneumonia
06/24
06/24
NCT06694701: Emapalumab Treatment for Anticipated Clinical Benefit in Sepsis Driven by the Interferon-Gamma Endotype (The EMBRACE Trial)

Recruiting
2
75
Europe
Emapalumab-Izsg, Emapalumab Group 1, Emapalumab Group 2, Placebo
Hellenic Institute for the Study of Sepsis
Sepsis
11/26
11/26
BIOARTE, NCT06141395: NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification

Completed
N/A
100
Europe
NGS-based assay for bacterial identification
Hellenic Institute for the Study of Sepsis, The BioArte
Pneumonia, Acute Pyelonephritis, Bacteremia, Biliary Tract Infection
03/24
03/24
HOMI-LUNG CAP, NCT06601998: Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.

Recruiting
N/A
650
Europe
Blood samples and Oropharyngeal swab, Six-minute walk test, Spirometry, ECG, Heart ultrasound and cardiopulmonary exercise stress testing, Completion of questionnaires of symptoms
Hellenic Institute for the Study of Sepsis
Pneumonia, Community-Acquired, COVID-19 Pneumonia, Cardiovascular Diseases
11/27
11/27
POINT, NCT06608849: The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated with the Post-acute Phase of the Infection by Covid-19

Recruiting
N/A
345
Europe
Blood samples, Six-minute walk test, Spirometry, HRCT, Heart ultrasound, Completion of questionnaires of symptoms
Hellenic Institute for the Study of Sepsis
Pulmonary Complications, Cardiovascular Complications, Renal Complications, COVID-19
11/27
11/27
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symbardi, Styliani
BEYOND, NCT05304715 / 2021-005473-10: Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection

Completed
2
44
Europe
Bezlotoxumab, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians., Normal saline 0.9% or 5% dextrose water, Standard-of-care treatment according to local guidelines or to the decision of the attending physicians
Hellenic Institute for the Study of Sepsis
Clostridioides Difficile Infection, Stool Microbiome, Organ Dysfunction Syndrome, Clostridioides Difficile Infection Recurrence, Mortality
06/23
06/23
INSPIRE, NCT05785442: Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia

Completed
2
60
Europe
Anakinra Prefilled Syringe, Kineret, Placebo, NaCl
Hellenic Institute for the Study of Sepsis
Community-acquired Pneumonia, Hospital-acquired Pneumonia
06/24
06/24
NCT06694701: Emapalumab Treatment for Anticipated Clinical Benefit in Sepsis Driven by the Interferon-Gamma Endotype (The EMBRACE Trial)

Recruiting
2
75
Europe
Emapalumab-Izsg, Emapalumab Group 1, Emapalumab Group 2, Placebo
Hellenic Institute for the Study of Sepsis
Sepsis
11/26
11/26
BIOARTE, NCT06141395: NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification

Completed
N/A
100
Europe
NGS-based assay for bacterial identification
Hellenic Institute for the Study of Sepsis, The BioArte
Pneumonia, Acute Pyelonephritis, Bacteremia, Biliary Tract Infection
03/24
03/24
HOMI-LUNG CAP, NCT06601998: Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19.

Recruiting
N/A
650
Europe
Blood samples and Oropharyngeal swab, Six-minute walk test, Spirometry, ECG, Heart ultrasound and cardiopulmonary exercise stress testing, Completion of questionnaires of symptoms
Hellenic Institute for the Study of Sepsis
Pneumonia, Community-Acquired, COVID-19 Pneumonia, Cardiovascular Diseases
11/27
11/27
POINT, NCT06608849: The Incidence of Pulmonary, Cardiovascular and Renal System Non-communicable Complications Associated with the Post-acute Phase of the Infection by Covid-19

Recruiting
N/A
345
Europe
Blood samples, Six-minute walk test, Spirometry, HRCT, Heart ultrasound, Completion of questionnaires of symptoms
Hellenic Institute for the Study of Sepsis
Pulmonary Complications, Cardiovascular Complications, Renal Complications, COVID-19
11/27
11/27

Download Options